This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market. Brands such as Wegovy and Zepbound -- the leading anti-obesity therapies -- are now well known and are generating billions of dollars in annual sales. That's why other drugmakers want to dip their toes in this lucrative and high-growth market.AbbVie (ABBV 1.68%) is one of them. The company, best known for its work in immunology, recently made a move to enter the weight loss spa ...